Cardiac dysfunction in portal hypertension among patients with cirrhosis and non-cirrhotic portal fibrosis

Journal of Hepatology

Volumn 39, Issue 3, 2003, Pages 315-319

  De, Binay K ^a   Majumdar, Debabrata ^a   Das, Debasish ^a   Biswas, Pranab K ^a   Mandal, Sanjay K ^a   Ray, Sujay ^a   Bandopadhyay, Kausik ^a   Das, Tapas K ^a   Dasgupta, Sanjay ^a   Guru, Supriya ^a  

^a INSTITUTE OF POST GRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Diastolic dysfunction; Non cirrhotic portal fibrosis; Portal hypertension

Indexed keywords

ALDOSTERONE; RENIN;

ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; ASCITES CELL; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLE; ECHOCARDIOGRAPHY; FEMALE; HEART DISEASE; HEART FUNCTION; HUMAN; LIVER CIRRHOSIS; LIVER FAILURE; LIVER FIBROSIS; MALE; PATHOGENESIS; PLASMA RENIN ACTIVITY; PORTAL HYPERTENSION; PRIORITY JOURNAL;

EID: 10744224974     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(03)00271-X     Document Type: Article

References (31)

1. Ma Z, Lee SS. Cirrhotic cardiomyopathy: getting to the heart of the matter. Hepatology 1996;24:451-459.
2. Pozzi M, Carugo S, Boari G, Pecci V, Ceglia SE, Maggiolini S, et al. Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites. Hepatology 1997;26:1131-1137.
3. Bernardi M, Rubboli A, Trevisani F, Cancellieri C, Ligabue A, Baraldini M, et al. Reduced cardiovascular responsiveness to exercise-induced sympatho-adrenergic stimulation in patients with cirrhosis. Hepatology 1991;12:207-216.
4. Grose RD, Nolan J, Dillon JF, Errington M, Hannan WJ, Bouchier IAD, et al. Exercise-induced left ventricular dysfunction in alcoholic and non-alcoholic cirrhosis. J Hepatol 1995;26:326-332.
5. Myers RP, Lee SS. Cirrhotic cardiomyopathy and liver transplantation. Liver Transpl 2000 Jul;6(Suppl. 1):S44-S52.
6. Grossman WE. Diastolic dysfunction and congestive heart failure. Circulation 1990;81(Suppl. III):1-7.
7. Wong F, Lie P, Lilly L, Bomzon A, Blendis L. Role of cardiac structural and functional abnormalities in the pathogenesis of hyperdynamic circulation and renal sodium retention in cirrhosis. Clin Sci 1999;97:259-267.
8. Valeriano V, Funaro S, Lionetti R, Riggio O, Pulcinelli G, Fiore P, et al. Modification of cardiac function in cirrhotic patients with and without ascites. Am J Gastroenterol 2000;95:3200-3205.
9. Lee SS, Marty J, Mantz J, Samain E, Braillon A, Lebrec D. Desensitization of myocardial β adrenergic receptors in cirrhotic rats. Hepatology 1990;12:481-485.
10. Battarbee HD, Zavecz JH. Cardiac performance in portal vein-stenosed rats. Am J Physiol 1992;263:G181-G185.
11. Basu AK, Boyer J, Bhattacharya R, Basu Mullick KC, Sengupta KP. Non-cirrhotic portal fibrosis with portal hypertension. Ind J Med Res 1967;55:336-351.
12. Okuda K, Nakashima T, Okudaira M. Liver pathology of idiopathic portal hypertension. Comparison with non-cirrhotic portal fibrosis of India. Liver 1982;2:176-192.
13. Benhamou JP, Valla D. Intrahepatic portal hypertension. In: Bircher J, Benhamou JP, McIntyre N, Rizzetto M, Rodes J, editors. Oxford textbook of hepatology, 2nd ed. New York: Oxford University Press Inc; 1999. p. 661-670.
14. Choong CY. Left ventricle V: diastolic function - its principles and evaluation. In: Weyman AE, editor. Principles and practice of echocardiography, 2nd ed. Pennsylvania: Lea & Febiger; 1994. p. 762.
15. Runyon BA. Ascites in liver disease. In: Haubrich WS, Schaffner F, Berk JE, editors. Bockus gastroenterology, vol. 3, 5th ed. Philadelphia: WB Saunders Company; 1995. p. 2004.
16. Research Society for Portal Hypertension, General rules for recording endoscopic findings of esophageal varices. Jpn J Surg 1980;10:84-87.
17. Pozzi M, Osculati G, Boari B, Serboli P, Lambrughi C, De Ceglia S, et al. Time course of circulatory and humoral effects of rapid total paracentesis in cirrhotic patients with tense refractory ascites. Gastroenterology 1994;106:709-719.
18. Sahn DJ, De Maria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-Mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58:1072-1083.
19. Henry VL, De Maria A, Gramiak R, King DL, Kisslo J, Popp RL, et al. Report of the American Society of Echocardiography: nomenclature and standards in two-dimensional echocardiography. Circulation 1980;62:212-217.
20. Triulzi MO, Castini D, Ornaghi M, Vitolo E. Effects of preload reduction on mitral flow velocity pattern in normal subjects. Am J Cardiol 1990;66:995-1001.
21. Kupari M, Koskinen P. Systolic flow velocity profile in the left ventricular outflow tract in persons free of heart disease. Am J Cardiol 1993;72:1172-1178.
22. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977;55:613-618.
23. Appelton CP, Firstenberg MS, Garcia MJ, Thomas JD. The echodoppler evaluation of left ventricular diastolic function - a current perspective. In: Cullen JH, editor. Diastolic function and dysfunction. Cardiology Clinics, 18. Philadelphia: WB Saunders Company; 2000 Aug. p. 513-546.
24. Guazzi M, Polese A, Magrini F, Fiorentini C, Olivari MT. Negative influences of ascites on the cardiac function of cirrhotic patients. Am J Med 1975;59:165-170.
25. Blendis L, Wong F. Is there a cirrhotic cardiomyopathy? Am J Gastroenterol 2000;95:3026-3028.
26. Rector Jr WG, Adair O, Hossack KF, Rainguet S. Atrial volume in cirrhosis: relationship to blood volume and plasma concentration of atrial natriuretic factor. Gastroenterology 1999;99:766-770.
27. Abelman WH. Editorial; hyperdynamic circulation in cirrhosis: a historical perspective, Hepatology 1994;20:1356-1358.
28. Kelback H, Eriksen J, Brynjolf I, Rabocl A, Lund JO, Munck O, et al. Cardiac performance in patients with asymptomatic alcoholic cirrhosis of the liver. Am J Cardiol 1984;54:852-855.
29. Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium: fibrosis and renin-angiotensin-aldosterone system. Circulation 1991;83:1849-1865.
30. Merli M, Valeriano V, Furano S, Attili AF, Masini A, Efarati C, et al. Modification of cardiac function in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt (TIPS). Am J Gastroenterol 2002;97:142-144.
31. Huonker M, Schumacher YO, Ochs A, Sorichter S, Keul J, Rossle M. Cardiac function and hemodynamics in alcoholic cirrhosis and the effects of the transjuglar intrahepatic portosystemic shunt. Gut 1999;44:743-774.